Loading
Molecular pathologist who co-founded Network Genomic Medicine and characterised lung cancer genomes.
Reinhard Büttner is Director of the Institute of Pathology at University Hospital Cologne (CIO). A molecular pathologist, his specialisms are molecular pathology, lung cancer genomics and predictive biomarkers, combining histopathology and immunohistochemistry with comprehensive genomic profiling. He co-founded Network Genomic Medicine and co-authored the Clinical Lung Cancer Genome Project analyses that defined targetable alterations in non-small-cell lung cancer. His papers include a review of PD-L1 immunohistochemistry assays and their clinical implementation in lung cancer, a study of KEAP1- and NFE2L2-mutated non-small-cell lung carcinoma, and a review of precision medicine in non-small-cell lung cancer. His publications are listed on PubMed.
| Title | Journal | Year |
|---|---|---|
| Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer | Journal of Clinical Oncology | 2017 |
| Clinical and Pathological Characteristics of KEAP1 - and NFE2L2 -Mutated Non–Small Cell Lung Carcinoma (NSCLC) | Clinical Cancer Research | 2018 |
| Precision medicine in non-small cell lung cancer: Current applications and future directions | Seminars in Cancer Biology | 2022 |
Shares Uniklinik Köln (CIO), nationales Netzwerk Genomische Medizin Lungenkrebs, Comprehensive genomic profiling, Non-small-cell lung cancer.
Shares nationales Netzwerk Genomische Medizin Lungenkrebs, Non-small-cell lung cancer.
Shares Histopathology & immunohistochemistry, Comprehensive genomic profiling, Non-small-cell lung cancer.
Shares Histopathology & immunohistochemistry, Comprehensive genomic profiling.
Shares Histopathology & immunohistochemistry, Comprehensive genomic profiling.
Shares Uniklinik Köln (CIO), nationales Netzwerk Genomische Medizin Lungenkrebs.
Shares Histopathology & immunohistochemistry, Comprehensive genomic profiling.